KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 165 days ( 1.49 % )
Last Price 5.55€ 0 %
High/ Low 5.55€ - 5.55€ 0%
Chg 7 Days N/A $5.55 5.55€
Chg 30 Days N/A $5.55 5.55€
Chg 12 mos -16.76 % $6.67 5.55€
Trend - 3 mos -0.511 % Width: 4.73 %
Trend - 12 mos -2.88 % Width: 87.77 %
Pred. range - 3 mos 5.50€ - 5.75€ -1.03 % - 3.65 %
Pred. range - 12 mos 3.91€ - 7.34€ -29.57 % - 32.24 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Sep 14, 2023 - 72 days
Long MA avg 12 mos Buy Sep 14, 2023 - 72 days
Short/Long MA avg 12 mos Sell Sep 19, 2023 - 69 days
Pivot Short Buy Sep 27, 2023 - 63 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Valneva SE

Valneva SE Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile tox... AYJ.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT